About Clarivate JCR-based Journal Impact Factors 2025
The Journal Impact Factor is a journal-level bibliometric indicator published by Clarivate in Journal Citation Reports (JCR). It is often abbreviated as JIF; JIF is not a separate impact factor, but simply the abbreviation for Journal Impact Factor.
The 2025 Journal Impact Factor provides a journal-level indication of citation activity. It should be interpreted within the journal’s subject area and together with other information, rather than used as a stand-alone judgment of research quality.
On this website, you can explore Journal Impact Factor records presented as Clarivate JCR-based data, together with the five-year Impact Factor, JCR quartile (Q1–Q4), JCR category rank, publisher details and journal identifiers. Verify important submission or evaluation decisions in the official Clarivate Journal Citation Reports.
Explore by research area
Browse journals by subject
Start with a broad research area, then narrow the list to a specialty or subsubject. These internal subject groups are provided for discovery and are kept separate from official Journal Citation Reports categories.
Popular specialties
Explore medical journal specialties
Browse focused journal lists within Medicine, including citation metrics, quartiles, publishers and identifiers.
Browse journal metrics
Showing records 791–800 of 20,480
| Rank | Journal | ISSN / eISSN | JCR Impact Factor | 5-Year Impact Factor | JCR Quartile | JCR Category Rank | Publisher |
|---|---|---|---|---|---|---|---|
| 775 |
Perspectives on Psychological Science PERSPECT PSYCHOL SCI |
1745-6916 1745-6924 |
8.400 | 11.900 | Q1 | 8/221 | SAGE PUBLICATIONS LTD |
| 775 |
Review of Finance REV FINANC |
1572-3097 1573-692X |
8.400 | 7.800 | Q1 | 6/241 | OXFORD UNIV PRESS |
| 775 |
SUPPLY CHAIN MANAGEMENT-AN INTERNATIONAL JOURNAL SUPPLY CHAIN MANAG |
1359-8546 1758-6852 |
8.400 | 10.800 | Q1 | 26/420 | EMERALD GROUP PUBLISHING LTD |
| 794 |
Annual Review of Virology ANNU REV VIROL |
2327-056X 2327-0578 |
8.300 | 11.900 | Q1 | Feb-42 | ANNUAL REVIEWS |
| 794 |
AUTOIMMUNITY REVIEWS AUTOIMMUN REV |
1568-9972 1873-0183 |
8.300 | 9.800 | Q1 | 16/183 | ELSEVIER |
| 794 |
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER BBA-REV CANCER |
0304-419X 1879-2561 |
8.300 | 11.600 | Q1 | May-79 | ELSEVIER |
| 794 |
BMC Medicine BMC MED |
1741-7015 1741-7015 |
8.300 | 9.400 | Q1 | 19/332 | BMC |
| 794 |
COMPUTERS ENVIRONMENT AND URBAN SYSTEMS COMPUT ENVIRON URBAN |
0198-9715 1873-7587 |
8.300 | 8.500 | Q1 | 5/173 | ELSEVIER SCI LTD |
| 794 |
EMBO JOURNAL EMBO J |
0261-4189 1460-2075 |
8.300 | 10.600 | Q1 | 30/319 | SPRINGERNATURE |
| 794 |
EMBO Molecular Medicine EMBO MOL MED |
1757-4676 1757-4684 |
8.300 | 10.000 | Q1 | 21/195 | SPRINGERNATURE |